Pure Global AI
NCT05677503Not yet recruiting

Determination of the Red Cell Distribution Width, NT-proBNP and cTnT in Acute Myocardial Infarction Patients

Determination of the Relationship Between Red Cell Distribution Width, NT-proBNP and cTnT in Acute Myocardial Infarction Patients
Sohag UniversityClinicalTrials.govdiagnostic test
Verified
Study focus
Disease/Condition
Myocardial Infarction
Drug/Device/Intervention
CBC
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Sohag University
Timeline & enrollment
Phase
N/A
Start date
Jan 15, 2023
End date
Jul 30, 2023
Enrollment
30 participants
Primary outcome

complete blood count (CBC),Level of (NT-proBNP),Level of (cTnT)

Summary

the study is to investigate the relationship of several parameters of complete blood count
 (CBC) including RDW with N-terminal pro-B-type natriuretic peptide (NT-proBNP) and cardiac
 troponin T (cTnT) in a cohort of acute myocardial infarction (AMI) patients.

ICD-10 classifications
Acute myocardial infarctionAcute myocardial infarction, unspecifiedOld myocardial infarctionSubsequent myocardial infarctionObservation for suspected myocardial infarction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05677503
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05677503 through Pure Global AI's free database. This phase not specified trial is sponsored by Sohag University and is currently Not yet recruiting. The study focuses on Myocardial Infarction. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.